policy
Use of technology in veterinary medicine
The AVMA supports responsible and ethical development and use of technology that can benefit and protect public health, animal health and welfare, and…
JAVMA news
Antimicrobial sales rise in 2018 but remain down over decade
Data show one-year rises among products for pigs, cattle
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Convention presenters dispense cannabis updates
Presentations on the research and regulations concerning the use of cannabis in veterinary medicine will be offered throughout the AVMA Virtual…
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
NIH funds development of novel Lyme disease vaccine
The grant is funding the efforts of tick immunobiologist Utpal Pal, PhD, to adapt the rabies vaccination platform to stimulate production of…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
Compounding
Understand the rules for veterinary compounding, and get resources to support your work with clients whose animals require compounded medications.
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
FDA guide helps drug companies report shortages
In May, agency officials published guidance on why those companies should share information about the animal drug supply chain and what details…
JAVMA news
Antimicrobial sales rise despite pending changes
Agreements between federal regulators and pharmaceutical companies are expected to reduce antimicrobial use in agriculture by the end of this year.
JAVMA news
AVMA president wants to hear from you
Dr. Douglas Kratt, AVMA president, hosted a virtual chat on Oct. 28, answering questions about everything from how he’s keeping productive at his…
JAVMA news
Pig drug may be withdrawn over residues
Food and Drug Administration officials are working to rescind approval of a swine-use drug that may leave carcinogenic residues in pork.
JAVMA news
CSU creates Sustainable Livestock Systems Collaborative
The Sustainable Livestock Systems Collaborative, the university announced this past December, will allow CSU livestock and animal health experts to…
JAVMA news
Recalled mirtazapine may have double the labeled strength
Mislabeled mirtazapine bottles could contain tablets with double the expected strength, according to a warning from the Food and Drug Administration.
JAVMA news
FDA approves Zoetis’ multiple-parasite preventive
Zoetis received approval in February from the Food and Drug Administration for its new Simparica Trio, the first combination drug that protects dogs…
JAVMA news
Nominations open for 2021 AVMA awards
The awards program recognizes contributions by veterinarians and nonveterinarians to the veterinary profession and to animal health and welfare.
JAVMA news
Busy times, stress for veterinarians during pandemic
The AVMA House of Delegates discussed how busy their practices are now, concerns they have for keeping themselves and their staff healthy, how to…
JAVMA news
NIFA awards $2.3 million to relieve veterinary shortages
The competitive grants awarded by the Department of Agriculture’s National Institute of Food and Agriculture are funded through the new Veterinary…
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
In Short
AVMA joins well-being group, horse sedative approved, electronic health certificates allowed
JAVMA news
AVMA leaders discuss potential legal liability of student, volunteer work
House of Delegates also talks about cannabis, telehealth
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.